Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Supernus PharmaceuticalsHeron TherapeuticsCorcept TherapeuticsInsmedMadrigal Pharmaceuticals
SymbolNASDAQ:SUPNNASDAQ:HRTXNASDAQ:CORTNASDAQ:INSMNASDAQ:MDGL
Price Information
Current Price$28.26$20.99$13.29$19.07$99.60
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$54.7143$56.40$14.3333$38.2857$178.6250
% Upside from Price Target93.61% upside168.70% upside7.85% upside100.76% upside79.34% upside
Trade Information
Market Cap$1.46 billion$1.64 billion$1.52 billion$1.70 billion$1.54 billion
Beta1.621.471.392.981.19
Average Volume543,722946,508977,3311,046,160200,654
Sales & Book Value
Annual Revenue$408.90 million$77.47 million$251.25 million$9.84 millionN/A
Price / Sales3.6221.636.01172.89N/A
Cashflow$2.4855 per shareN/A$0.6512 per shareN/AN/A
Price / Cash11.37N/A20.41N/AN/A
Book Value$8.67 per share$4.74 per share$2.39 per share$2.70 per share$30.99 per share
Price / Book3.264.435.567.06N/A
Profitability
Net Income$110.99 million$-178,840,000.00$75.41 million$-324,280,000.00$-32,810,000.00
EPS$2.05($2.44)$0.60($4.17)($2.22)
Trailing P/E Ratio13.79N/A22.15N/AN/A
Forward P/E Ratio14.57N/A14.14N/AN/A
P/E Growth$0.98N/AN/AN/AN/A
Net Margins25.66%-172.07%29.16%N/AN/A
Return on Equity (ROE)22.36%-56.89%27.97%-126.95%-11.62%
Return on Assets (ROA)10.52%-45.19%24.84%-47.66%-11.38%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.70%0.04%N/A1.01%N/A
Current Ratio2.72%4.01%7.66%7.54%38.06%
Quick Ratio2.53%3.70%7.49%7.31%38.06%
Ownership Information
Institutional Ownership Percentage99.34%N/A75.10%N/A61.77%
Insider Ownership Percentage6.57%12.56%15.50%4.95%47.69%
Miscellaneous
Employees44819816637317
Shares Outstanding52.45 million79.82 million113.69 million89.21 million15.43 million
Next Earnings Date11/5/2019 (Estimated)11/6/2019 (Estimated)11/7/2019 (Estimated)10/29/2019 (Estimated)11/5/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Supernus PharmaceuticalsHeron TherapeuticsCorcept TherapeuticsInsmedMadrigal Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel